Skip to main content
Top
Published in: World Journal of Surgery 2/2016

01-02-2016 | Original Scientific Report

Presentation and Outcomes After Surgery for Primary Hyperparathyroidism During an 18-Year Period

Authors: Mark Thier, Erik Nordenström, Anders Bergenfelz, Martin Almquist

Published in: World Journal of Surgery | Issue 2/2016

Login to get access

Abstract

Purpose

The objective of this study is to analyze whether the trend towards operating on patients with less severe primary hyperparathyroidism (pHPT) than earlier is reflected in a change of preoperative presentation and surgical outcome.

Methods

In this longitudinal cohort study, patients with pHPT subjected to first time surgery were compared in three time periods: 1989–1994, 1995–2000, and 2001–2006 in this longitudinal cohort study.

Results

There were 404 patients. Median levels of preoperative ionized calcium were lower in 2001–2006 compared to 1989–1994; 1.45 versus 1.50 versus 1.45 mmol/L; p < 0.001. Preoperative parathyroid hormone levels in patients with parathyroid adenoma were lower in 2001–2006 than in 1989–1994; 10.0 versus 11.6 pmol/L; p 0.04. Median preoperative bone mineral density, BMD, in the whole cohort did not differ between time periods. Median pre- and postoperative glomeruli filtration rate, GFR, and 25-hydroxy-vitamin D3 remained unchanged between period 1 and period 3. Adenoma weight was lower in 2001–2006 than 1989–1994; 0.70 versus 0.50 g; p 0.04. Cure rate did not change during observation time. There was no evidence for differences in change of BMD (femoral neck) after surgery between period 2 and 3 1995–2000 and 2001–2006, 0.798 versus 0.795 g/cm2; p 0.67. GFR did not change significantly between 1989–1994 and 2001–2006, 74 versus 77 mL/min; p 0.43.

Conclusions

A significant change towards operating patients with smaller adenomas and lower preoperative calcium levels was evident throughout the observation period, but this did not correlate with differences in preoperative renal or skeletal function. We found no evidence for a change of postoperative renal function or skeletal function during observation time.
Literature
1.
go back to reference Mandl F (1926) Therapeutischer Versuch bei einem Fall von Ostitis fibrosa generalisata mittels Extirpation eines Epithelkoerperchentumors. Zentralbl f Chir 53(260):56 Mandl F (1926) Therapeutischer Versuch bei einem Fall von Ostitis fibrosa generalisata mittels Extirpation eines Epithelkoerperchentumors. Zentralbl f Chir 53(260):56
2.
go back to reference Almquist M et al (2010) Changing biochemical presentation of primary hyperparathyroidism. Langenbecks Arch Surg 395(7):925–928PubMedCrossRef Almquist M et al (2010) Changing biochemical presentation of primary hyperparathyroidism. Langenbecks Arch Surg 395(7):925–928PubMedCrossRef
3.
go back to reference Lo CY et al (2004) Surgical treatment for primary hyperparathyroidism in Hong Kong: changes in clinical pattern over 3 decades. Arch Surg 139(1):77–82 (discussion 82) PubMedCrossRef Lo CY et al (2004) Surgical treatment for primary hyperparathyroidism in Hong Kong: changes in clinical pattern over 3 decades. Arch Surg 139(1):77–82 (discussion 82) PubMedCrossRef
4.
go back to reference Mazzaglia PJ et al (2008) The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 143(3):260–266PubMedCrossRef Mazzaglia PJ et al (2008) The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 143(3):260–266PubMedCrossRef
5.
go back to reference McCoy KL et al (2014) The small abnormal parathyroid gland is increasingly common and heralds operative complexity. World J Surg 38(6):1274–1281PubMedCrossRef McCoy KL et al (2014) The small abnormal parathyroid gland is increasingly common and heralds operative complexity. World J Surg 38(6):1274–1281PubMedCrossRef
6.
go back to reference Mundy GR, Cove DH, Fisken R (1980) Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1(8182):1317–1320PubMedCrossRef Mundy GR, Cove DH, Fisken R (1980) Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1(8182):1317–1320PubMedCrossRef
7.
go back to reference Ohe MN et al (2005) Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985 to 2002. Braz J Med Biol Res 38(9):1383–1387PubMedCrossRef Ohe MN et al (2005) Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985 to 2002. Braz J Med Biol Res 38(9):1383–1387PubMedCrossRef
8.
go back to reference Palmer M et al (1987) Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. J Chronic Dis 40(2):121–130PubMedCrossRef Palmer M et al (1987) Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. J Chronic Dis 40(2):121–130PubMedCrossRef
9.
go back to reference Rajaei MH et al (2014) Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol 22(2):454–459PubMedPubMedCentralCrossRef Rajaei MH et al (2014) Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol 22(2):454–459PubMedPubMedCentralCrossRef
10.
go back to reference Mihai R et al (2009) Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg 394(5):785–798PubMedCrossRef Mihai R et al (2009) Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg 394(5):785–798PubMedCrossRef
11.
go back to reference Mihai R et al (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30(5):697–704. doi:10.1007/s00423-009-0522-8 PubMedCrossRef Mihai R et al (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30(5):697–704. doi:10.​1007/​s00423-009-0522-8 PubMedCrossRef
12.
13.
go back to reference Brockstedt H et al (1995) Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 16(1):109–117PubMedCrossRef Brockstedt H et al (1995) Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 16(1):109–117PubMedCrossRef
14.
go back to reference Christiansen P (2001) The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. APMIS 102:1–52 Christiansen P (2001) The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. APMIS 102:1–52
15.
go back to reference Christiansen P et al (1999) Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study. Bone 25(5):597–602PubMedCrossRef Christiansen P et al (1999) Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study. Bone 25(5):597–602PubMedCrossRef
16.
go back to reference Nakaoka D et al (2000) Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism. Endocr J 47(3):231–237PubMedCrossRef Nakaoka D et al (2000) Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism. Endocr J 47(3):231–237PubMedCrossRef
17.
go back to reference Nomura R et al (2004) Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clin Endocrinol (Oxf) 60(3):335–342CrossRef Nomura R et al (2004) Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clin Endocrinol (Oxf) 60(3):335–342CrossRef
18.
go back to reference Rolighed L et al (2013) BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg 398(1):113–120PubMedCrossRef Rolighed L et al (2013) BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg 398(1):113–120PubMedCrossRef
20.
go back to reference Tassone F et al (2009) Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 94(11):4458–4461PubMedCrossRef Tassone F et al (2009) Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 94(11):4458–4461PubMedCrossRef
21.
go back to reference Moosgaard B et al (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63(5):506–513CrossRef Moosgaard B et al (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63(5):506–513CrossRef
22.
go back to reference Irvin GL 3rd, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162(4):299–302PubMedCrossRef Irvin GL 3rd, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162(4):299–302PubMedCrossRef
24.
go back to reference Lundstam K et al (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100(4):1359–1367PubMedCrossRef Lundstam K et al (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100(4):1359–1367PubMedCrossRef
25.
go back to reference Silverberg SJ (2000) Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am 29(3):451–464PubMedCrossRef Silverberg SJ (2000) Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am 29(3):451–464PubMedCrossRef
26.
go back to reference Vera L et al (2014) Five-year longitudinal evaluation of mild primary hyperparathyroidism—medical treatment versus clinical observation. Endokrynol Pol 65(6):456–463PubMedCrossRef Vera L et al (2014) Five-year longitudinal evaluation of mild primary hyperparathyroidism—medical treatment versus clinical observation. Endokrynol Pol 65(6):456–463PubMedCrossRef
27.
go back to reference Yu N et al (2011) The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM 104(6):513–521PubMedCrossRef Yu N et al (2011) The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM 104(6):513–521PubMedCrossRef
28.
go back to reference Nikkila MT, Saaristo JJ (1989) Serum vitamin D metabolite concentrations in primary hyperparathyroidism. Ann Med 21(4):281–283PubMedCrossRef Nikkila MT, Saaristo JJ (1989) Serum vitamin D metabolite concentrations in primary hyperparathyroidism. Ann Med 21(4):281–283PubMedCrossRef
29.
go back to reference Nordenstrom E et al (2013) Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from southern and northern europe. Int J Endocrinol 2013:164939PubMedPubMedCentralCrossRef Nordenstrom E et al (2013) Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from southern and northern europe. Int J Endocrinol 2013:164939PubMedPubMedCentralCrossRef
30.
go back to reference Nuti R, Merlotti D, Gennari L (2011) Vitamin D deficiency and primary hyperparathyroidism. J Endocrinol Investig 34(7 Suppl):45–49 Nuti R, Merlotti D, Gennari L (2011) Vitamin D deficiency and primary hyperparathyroidism. J Endocrinol Investig 34(7 Suppl):45–49
31.
go back to reference Hedback G, Abrahamsson K, Oden A (2001) The improvement of renal concentration capacity after surgery for primary hyperparathyroidism. Eur J Clin Investig 31(12):1048–1053CrossRef Hedback G, Abrahamsson K, Oden A (2001) The improvement of renal concentration capacity after surgery for primary hyperparathyroidism. Eur J Clin Investig 31(12):1048–1053CrossRef
Metadata
Title
Presentation and Outcomes After Surgery for Primary Hyperparathyroidism During an 18-Year Period
Authors
Mark Thier
Erik Nordenström
Anders Bergenfelz
Martin Almquist
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 2/2016
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3329-5

Other articles of this Issue 2/2016

World Journal of Surgery 2/2016 Go to the issue